The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination.
Chiarle R; Martinengo C; Mastini C; Ambrogio C; D'Escamard V; Forni G; Inghirami G; Nature Medicine, 2008, vol. 14, issue 6, p 676, ISSN 1546170x. ISBN 1546170x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef